Skip to search.
 TSX Down 0.19% TSX Ventures Up 0.14%

OncoGenex Pharmaceuticals, Inc. (OGXI)

-NasdaqCM
0.51 Up 0.04(7.87%) Sep 30, 4:00PM EDT
Prev Close:0.47
Open:0.46
Bid:0.30 x 1000
Ask:1.35 x 20000
1y Target Est:1.95
Beta:1.9857
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:0.46 - 0.51
52wk Range:0.46 - 2.80
Volume:217,100
Avg Vol (3m):240,605
Market Cap:15.21M
P/E (ttm):N/A
EPS (ttm):-0.57
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
OGXIUp 7.87%15.21M
CELGUp 1.71%81.02B
PFEUp 1.65%205.44B
BMYUp 0.09%90.09B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):0.79
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.82
Quarterly EPS Est (Sep-16) :-0.26
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

OncoGenex Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback